A novel in vivo Cerenkov luminescence image-guided surgery on primary and metastatic colorectal cancer

  • Zeyu Zhang
  • , Yawei Qu
  • , Yu Cao
  • , Xiaojing Shi
  • , Hongbo Guo
  • , Xiaojun Zhang
  • , Sheng Zheng
  • , Haifeng Liu*
  • , Zhenhua Hu
  • , Jie Tian
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Intraoperative Cerenkov luminescence imaging (CLI) can effectively improve the performance of tumor surgery. Nevertheless, the existing approaches are still unsatisfying to the clinical demands of open surgery. This study develops a novel intraoperative in vivo CLI approach to investigate the potential and value of Cerenkov luminescence (CL) image-guided surgery. A system characterized with high sensitivity (19.61 kBq mL−1 18F-FDG) and desirable spatial resolution (88.34 μm) is developed. CL image-guided surgery is performed on colorectal cancer (CRC) models of mice and swine. Tumor surgery is guided by the static CL images, and the resection quality is evaluated quantitatively and contrasted with other imaging modalities exemplified by bioluminescence imaging (BLI). The in vivo results demonstrated the effectiveness of the proposed intraoperative CLI approach for removing primary and metastatic CRC. Safety of performing in vivo CL image-guided surgery is verified as well through radiation measurements of related staffs. Overall, the developed intraoperative in vivo CLI approach can efficiently improve the cancer treatment.

Original languageEnglish
Article numbere201960152
JournalJournal of Biophotonics
Volume13
Issue number3
DOIs
StatePublished - 1 Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cerenkov luminescence imaging
  • colorectal cancer
  • image-guided surgery
  • in vivo

Fingerprint

Dive into the research topics of 'A novel in vivo Cerenkov luminescence image-guided surgery on primary and metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this